Background: Hyperinsulinemia results from β-cell ompensatory adaptation to insulin resistance and reduced insulin clearance. We examined the relationship between hepatic/peripheral insulin clearance and β-cell function in lean and obese insulin sensitive (IS) and insulin resistant (IR) adolescents.

Methods: A 2-step euglycemic hyperinsulinemic clamp and an hyperglycemic clamp were performed in 153 youths (73F, 14.4±3.3y) to evaluate hepatic (MCR1) and peripheral (MCR2) insulin clearance, β-cell function (DIcpep) and insulin sensitivity. Participants were grouped as:non-Obese NGT (nOb-NGT, n=23), obese NGT-IS (Ob-NGT-IS, n=47), obese NGT-IR (Ob-NGT-IR, n=47), and obese IGT (Ob-IGT, n=36). IS and IR were defined according to the median M (glucose disposal) from euglycemic clamp. Effect of MCR1-2, sex, age, BMI, Tanner stage, fasting/2h-glucose, ethnicity on DIcpepwas estimated by multivariate regression model.

Results: IS, MCR1/MCR2 did not differ between nOb-NGT and Ob-NGT-IS. MCR1 was lower in Ob-NGT-IR and Ob-IGT than nOb-NGT, while MCR2 only declined in the Ob-IGT. (upper panels) MCR1 and MCR2 were the sole determinants of DIcpep (p0.006 and p0.015), as confirmed by ~50% reduction in DIcpep of the lowest tertiles of MCR1 and MCR2. (lower panels).

Conclusion: In obese adolescents, lower MCR1 and MCR2 are independently associated with a blunted β-cell function thus playing a key role in youth onset T2D.


A. Galderisi: None. D. Trico: None. C. Giannini: None. N. Santoro: None. S. Caprio: None. R. Weiss: Consultant; Self; Medtronic MiniMed, Inc.


National Institutes of Health (R01DK085577-01, R01HD40787, R01HD28016, P30DK045735, K12DK094714-02, R01DK111038-01A1); Robert E. Leet and Clara Guthrie Patterson Trust; European Medical International Framework (EMIF115372)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at